 |
인쇄하기
취소
|
UCB Korea's Xyzal to get approval of additional indications.
Xyzal tab. of UCB Korea, an anti-histaminic drug, took an additional approval for the treatment of allergic rhinitis from the KFDA.
The company said that of all anti-histaminics only Xyzal took the indication for the treatment of allergic rhinitis from the health authority.
The KFDA said that the Xyzal's additional indication for the treatment of allergic rhinitis was based on the XPERT 3...
The company said that of all anti-histaminics only Xyzal took the indication for the treatment of allergic rhinitis from the health authority.
The KFDA said that the Xyzal's additional indication for the treatment of allergic rhinitis was based on the XPERT 3...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.